Posted by Michael Wonder on 23 Oct 2025
New ICER report shows significant jump in launch prices, exceeding inflation and GDP growth
23 October 2025 - Nearly $1.5 billion could have been saved in one year alone if prices matched ICER value estimates; patient access often hindered by delayed insurance coverage policies.
The ICER today released its new “Launch Price and Access Report,” finding that drug launch prices continue to rise at a rate that exceeds inflation, gross domestic product growth, and overall health care costs.
